Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

7 treatments under study, led by Gp Iibiiia Inhibitor Or Heparin Dual Antiplatelet Therapy

Research Leaders

6 sponsors active, led by Peking Union Medical College Hospital

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 15/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 3 (1)

Trial Status

Not Yet Recruiting1
Unknown1
Completed1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT07783880Not ApplicableNot Yet Recruiting

Investigation to Assess the Effects of Drug-COATED Balloons for Treatment of Plaques Erosions Causing Acute Coronary Syndromes

NCT06702917Active Not RecruitingPrimary

GSI Cardiac on Revolution Apex - US

NCT05497466Unknown

PUMCH Study Into Individualized Scanning for Coronary Artery Disease

NCT02171247Phase 3CompletedPrimary

Comparison of Isovue 370 vs. Standard Protocol in Coronary Computed Tomographic Angiography (CTA)

Showing all 4 trials

Research Network

Common Treatments

  • Gp Iibiiia Inhibitor Or Heparin Dual Antiplatelet Therapy1
  • Standard Of Care Ccta1
  • Pci With Size Matched Dcb1
  • Isovue 3701
  • Gsi Cardiac Scan1

Active Sponsors

  • Peking Union Medical College Hospital1
  • University of Washington1
  • GE Healthcare1
  • 3W-Research Collaboration Group1
  • Duke University1

Top Investigators

Related Conditions

  • Coronary Artery Disease1
  • Computed Tomography1
  • Medical Treatment1
  • Cardiac Catheterization1
  • Optical Coherence Tomography Oct1

Activity Timeline